Christopher Barron
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2025First federal award
$2.4MFederal grants as PI3 awards
1Patents grantedLatest Dec 16, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $2.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 11, 2026 | NIH | SBIR Phase II CuRrEnT: Capecitabine in RCB2/3 with a wearable induced Electric field device in Triple Negative Breast Cancer | $870K | EMBIOSYS INC. |
| Sep 17, 2025 | NIH | SBIR Phase II CuRrEnT: Capecitabine in RCB2/3 with a wearable induced Electric field device in Triple Negative Breast Cancer | $1.4M | EMBIOSYS INC. |
| Jun 18, 2025 | NIH | SBIR Phase I DEVELOPMENT OF A WEARABLE, NON-INVASIVE, TREATMENT DEVICE FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC) | $189K | EMBIOSYS INC. |
2 patents as inventor
- US 12496455EMBIOSYS INC.Dec 16, 2025
- US EMBIOSYS INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#883
Awards as PI#927
Patents#284
Companies
- EMBIOSYS INC.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.